• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手性和非手性阴离子3-羟基吡啶-4-酮对铁的动员作用

Mobilization of iron by chiral and achiral anionic 3-hydroxypyrid-4-ones.

作者信息

Molenda J J, Jones M M, Johnston D S, Walker E M, Cannon D J

机构信息

Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235.

出版信息

J Med Chem. 1994 Dec 9;37(25):4363-70. doi: 10.1021/jm00051a014.

DOI:10.1021/jm00051a014
PMID:7996548
Abstract

In the search for 3-hydroxypyrid-4-ones with enhanced iron-mobilizing ability, seven chiral, anionic amino acid derivatives of maltol (3-hydroxy-2-methyl-4-pyrone) have been synthesized, utilizing L-methionine, L-serine, L-leucine, L-phenylalanine, L-glutamic acid, and the D- and L-isomers of alanine. Two achiral, aromatic compounds were also synthesized and compared with the phenylalanine derivative. The biliary iron excretion following iv injection and the urinary iron excretion following po administration were measured using female Sprague-Dawley rats and compared to that of the standard, 1,2-dimethyl-3-hydroxypyrid-4-one (L1). While none of the compounds was as effective as L1 in enhancing the urinary excretion of iron, all monoanionic chelators increased excretion relative to the controls. All monoanionic compounds were at least equivalent to L1 in enhancing the biliary excretion of iron, with the methionine, leucine, and benzoate derivatives surpassing the standard and the other aromatic compounds also showing strong activity. The dianionic glutamate derivative showed low activity relative to the controls for both urinary and biliary iron excretion. No significant difference in iron excretion was observed due to variation in chirality; molecular weight and the number of negative charges appeared to have the greatest influence on the ability of the various derivatives to enhance iron excretion. In order to evaluate the relative purity of the stereoisomers, the alanine derivatives were analyzed by circular dichroism. Further characterization was provided by UV/vis spectroscopy for all compounds and X-ray crystallography for the novel dianionic derivative.

摘要

为了寻找具有增强铁动员能力的3-羟基吡啶-4-酮,利用L-甲硫氨酸、L-丝氨酸、L-亮氨酸、L-苯丙氨酸、L-谷氨酸以及丙氨酸的D-和L-异构体,合成了麦芽酚(3-羟基-2-甲基-4-吡喃酮)的七种手性阴离子氨基酸衍生物。还合成了两种非手性芳香化合物,并与苯丙氨酸衍生物进行比较。使用雌性Sprague-Dawley大鼠测量静脉注射后的胆汁铁排泄量和口服给药后的尿铁排泄量,并与标准品1,2-二甲基-3-羟基吡啶-4-酮(L1)进行比较。虽然没有一种化合物在增强尿铁排泄方面像L1那样有效,但所有单阴离子螯合剂相对于对照组都增加了排泄量。所有单阴离子化合物在增强胆汁铁排泄方面至少与L1相当,甲硫氨酸、亮氨酸和苯甲酸盐衍生物超过了标准品,其他芳香化合物也表现出很强的活性。二阴离子谷氨酸衍生物在尿铁和胆汁铁排泄方面相对于对照组表现出低活性。由于手性的变化未观察到铁排泄有显著差异;分子量和负电荷数量似乎对各种衍生物增强铁排泄的能力影响最大。为了评估立体异构体的相对纯度,通过圆二色性分析了丙氨酸衍生物。通过紫外/可见光谱对所有化合物进行了进一步表征,并通过X射线晶体学对新型二阴离子衍生物进行了表征。

相似文献

1
Mobilization of iron by chiral and achiral anionic 3-hydroxypyrid-4-ones.手性和非手性阴离子3-羟基吡啶-4-酮对铁的动员作用
J Med Chem. 1994 Dec 9;37(25):4363-70. doi: 10.1021/jm00051a014.
2
Enhancement of iron excretion via monoanionic 3-hydroxypyrid-4-ones.通过单阴离子3-羟基吡啶-4-酮增强铁排泄
J Med Chem. 1994 Jan 7;37(1):93-8. doi: 10.1021/jm00027a011.
3
Synthesis and iron(III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid.源自曲酸的3-羟基吡啶-4-酮的合成及与铁(III)的结合特性
J Inorg Biochem. 1994 Aug 1;55(2):131-46. doi: 10.1016/0162-0134(94)85035-6.
4
Structure/activity relationships affecting the ability of monoanionic 3-hydroxyprid-4-ones to mobilize iron.影响单阴离子3-羟基吡啶-4-酮动员铁能力的结构/活性关系。
Chem Res Toxicol. 1994 Nov-Dec;7(6):815-22. doi: 10.1021/tx00042a015.
5
Biliary excretion of plasma non-transferrin-bound iron in rats: pathogenetic importance in iron-overload disorders.大鼠血浆非转铁蛋白结合铁的胆汁排泄:铁过载疾病中的发病机制重要性
Am J Physiol. 1994 Jul;267(1 Pt 1):G135-42. doi: 10.1152/ajpgi.1994.267.1.G135.
6
Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.选择用于治疗铁过载的新一代口服活性α-酮羟基吡啶铁螯合剂。
Am J Hematol. 1993 Apr;42(4):340-9. doi: 10.1002/ajh.2830420403.
7
Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.新型1-烷基-3-羟基-2-甲基吡啶-4-酮螯合剂对巨噬细胞摄取和释放铁的影响。
Am J Hematol. 1990 May;34(1):21-5. doi: 10.1002/ajh.2830340106.
8
Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats.
J Hepatol. 1997 Jul;27(1):176-84. doi: 10.1016/s0168-8278(97)80299-1.
9
In vivo evaluation of hydroxypyridone iron chelators in a mouse model.在小鼠模型中对羟基吡啶酮铁螯合剂进行体内评估。
Acta Haematol. 1987;78(2-3):217-21. doi: 10.1159/000205878.
10
Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
Mol Pharmacol. 1986 Dec;30(6):670-3.

引用本文的文献

1
Atom-Economic Synthesis of 4-Pyrones from Diynones and Water.由二炔酮和水进行4-吡喃酮的原子经济性合成
Molecules. 2017 Jan 10;22(1):109. doi: 10.3390/molecules22010109.